No Data
No Data
Investors Appear Satisfied With Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Prospects
Express News | Cytek Biosciences Announces $50 Million Stock Repurchase Program
Cytek Biosciences to Participate at the Goldman Sachs 45th Annual Global Healthcare Conference
Sector Update: Health Care Stocks Lean Lower Premarket Wednesday
Express News | Cytek Biosciences Says Its 1-laser And 2-laser 6-color TBNK Reagent Cocktails Have Received China NMPA Approval For Clinical Diagnostic Use
Express News | 1-Laser and 2-Laser 6-Color Tbnk Reagents From Cytek® Biosciences Approved for Clinical Use in China